Inventor · disambiguated record
Kai C. Wollert
Also filed as: WOLLERT KAI C · WOLLERT KAI CHRISTOPH
3 granted patents·4 pending applications·0 citations·filing 2009–2023
47Inventor score
Files withBOEHRINGER INGELHEIM INT3MEDIZINISCHE HOCHSCHULE HANNOVER2HANNOVER MED HOCHSCHULE1WOLLERT KAI C1
Top patents by PatentIndex Score
7 records- 0161US11199552B2Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereofMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2019·Granted Dec 14, 2021·0 cites·8 claims
- 0259US2025333459A1Recombinant expression of myeloid-derived growth factorBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0354US2025325704A1Viral capsid proteins with specificity to heart tissue cellsBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 0446US8951742B2Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of GDF-15, natriuretic peptide, cardiac troponin or combinations thereofWOLLERT KAI C·Filed 2009·Granted Feb 10, 2015·0 cites·35 claims
- 0543US2023059560A1Myeloid-derived growth factor for use in treating or preventing fibrosis, hypertrophy or heart failureBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 0639US10369198B2Factor 1 protein, factor 2 protein and inhibitors thereof for use in treating or preventing diseasesMEDIZINISCHE HOCHSCHULE HANNOVER·Filed 2014·Granted Aug 6, 2019·0 cites·9 claims
- 0732US2015362511A1Assessing susceptibility to cardiac intervention, susceptibility to therapy for heart failure, risk of mortality or further cardiovascular events, and risk of subsequent pulmonary embolism in relevant patients based on determinations of gdf-15, natriuretic peptide, cardiac troponin or combinations thereofHANNOVER MED HOCHSCHULE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kai C. Wollert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →